Trademark Overview
On Friday, August 24, 2001, a trademark application was filed for GENOMEVISION with the United States Patent and Trademark Office. The USPTO has given the GENOMEVISION trademark a serial number of 76303948. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, February 9, 2004. This trademark is owned by Genome Therapeutics Corporation. The GENOMEVISION trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals, namely, pharmaceutical compounds, therapeutic agents, and biotechnologic substances incorporating the results of genomic research, namely, drugs and anti-infective agents for use in combating resistant infectious diseases for human, veterinary and agricultural applications; reagents, namely, diagnostic reagents for clinical or medical laboratory use
Computer software, featuring a database used for genetic or protein analysis; computer hardware and computer peripherals; DNA micro array chips; scientific instruments, namely, DNA sequencers, PCR machines, clone picking robots, DNA preparation used in the preparation and separation of DNA sequences
Biotechnology research and development services in the field of genome research, namely, genetic sequencing; genomic library sequencing services; library construction services; library screening services; single nucleotide polymorphorisms (SNP) detection and screening services, namely, performing functional assays of genes, sequencing genes, identifying and characterizing genes; micro array services, namely, gene sequencing typing and chemical compound screening and gene expression micro array image analysis; high throughput screening services; bioninformatic services, namely, protein identification, characterization and analysis in the field of biomedical research; genomic assembly and finishing services; gene mapping and fingerprinting services; amplification services, namely, gene cloning identification services; biotechnological research and development services, namely, drug target identification and characterization; medical and scientific research, namely, conducting clinical tr...